Both in Pharmaceuticals
Lexicon Pharmaceuticals vs Immix Biopharma
Over the past year LXRX returned +4.4% and IMMX returned +111.0%; their daily moves had a correlation of 0.27.
LXRX +4.4% IMMX +111.0%Growth of $1, one year, split-adjusted
| Metric | LXRX | IMMX |
|---|---|---|
| Price | $1.42 | $7.68 |
| Market cap | $631.8M | $636.7M |
| Today | −4.05% | −3.76% |
| 1 month | −22.0% | −24.9% |
| 6 months | −12.9% | −17.4% |
| Year to date | +23.5% | +46.8% |
| 1 year | +6.8% | +106.5% |
| Revenue growth (YoY) | −97.6% | — |
| Gross margin | 94.4% | — |
| Net margin | −4591.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 15.3× | — |
| Net cash | $139.2M | $232.1M |
| Dividend yield | — | — |
| Volatility (60d) | 52.9% | 68.2% |
| Short % of float | 11.8% | 22.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).